BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7117370)

  • 1. Serotonin-like actions of quipazine and CPP on spinal motoneurones.
    Neuman RS; White SR
    Eur J Pharmacol; 1982 Jun; 81(1):49-56. PubMed ID: 7117370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of serotonin receptor agonists and antagonists on schedule-controlled behavior of squirrel monkeys.
    Brady LS; Barrett JE
    J Pharmacol Exp Ther; 1985 Nov; 235(2):436-41. PubMed ID: 2932546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of quipazine, a serotonin receptor agonist, on serum corticosterone concentration in rats.
    Fuller RW; Snoddy HD; Clemens JA
    Endocr Res Commun; 1978; 5(2):161-71. PubMed ID: 309816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metergoline and quipazine on locomotor activity of rats in novel and familiar environments.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 May; 20(5):701-5. PubMed ID: 6739514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denervation supersensitivity to 5-hydroxytryptamine in the rat spinal cord is not due to the absence of 5-hydroxytryptamine.
    Tremblay LE; Bédard PJ; Maheux R; Di Paolo T
    Brain Res; 1985 Mar; 330(1):174-7. PubMed ID: 3157425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rats and marmosets respond differently to serotonin agonists and antagonists.
    Campos MF; Rodrigues F das C
    Psychopharmacology (Berl); 1987; 92(4):478-83. PubMed ID: 3114802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of suprachiasmatic neurons of the rat hypothalamus to photic and serotonergic stimulation.
    Miller JD; Fuller CA
    Brain Res; 1990 May; 515(1-2):155-62. PubMed ID: 2357553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A serotonin agonist-antagonist reversible effect on Na+-K+-ATPase activity in the developing rat brain.
    Hernández RJ
    Dev Neurosci; 1982; 5(4):326-31. PubMed ID: 6291893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced activation of the inferior olivary nucleus in young rabbits. Differential effects of harmaline and quipazine.
    Barragan LA; Delhaye-Bouchaud N; Laget P
    Neuropharmacology; 1985 Jul; 24(7):645-54. PubMed ID: 3160966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
    Lucki I; Ward HR; Frazer A
    J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
    Grome JJ; Harper AM
    J Neurochem; 1986 Jan; 46(1):117-24. PubMed ID: 3940273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological antagonism of facilitatory but not inhibitory effects of serotonin and norepinephrine on excitability of spinal motoneurons.
    White SR; Neuman RS
    Neuropharmacology; 1983 Apr; 22(4):489-94. PubMed ID: 6134247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline.
    White SR; Neuman RS
    Brain Res; 1980 Apr; 188(1):119-27. PubMed ID: 7370747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of quipazine on blood pressure in pithed rats.
    Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
    Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Hydroxytryptamine agonistic action of methysergide and the absence of supersensitivity to 5-HT agonists in spinal flexor reflexes in rats.
    Ono H; Miyamoto M; Kobayashi M; Fukuda H
    Neuropharmacology; 1987 Sep; 26(9):1371-5. PubMed ID: 3670560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 5-hydroxytryptamine agonists and antagonists on the responses of rat spinal motoneurones to raphe obscurus stimulation.
    Roberts MH; Davies M; Girdlestone D; Foster GA
    Br J Pharmacol; 1988 Oct; 95(2):437-48. PubMed ID: 3228671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic facilitation of facial motoneuron excitation.
    McCall RB; Aghajanian GK
    Brain Res; 1979 Jun; 169(1):11-27. PubMed ID: 156574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of quipazine on pre- and postsynaptic serotonin receptors: single cell studies in the rat CNS.
    Blier P; de Montigny C
    Neuropharmacology; 1983 Apr; 22(4):495-9. PubMed ID: 6856049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats.
    Van de Kar LD; Wilkinson CW; Ganong WF
    J Pharmacol Exp Ther; 1981 Oct; 219(1):85-90. PubMed ID: 6457138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.